Dialysis News and Research

Latest Dialysis News and Research

Combination of Baxter and Gambro enable Baxter to better serve innovative renal products and therapies

Baxter International Inc. (NYSE: BAX) today announced that the company has successfully completed the acquisition of Gambro AB, a privately held global medical technology company and leader in dialysis products based in Lund, Sweden.

From Baxter International Inc. 7 Sep 2013

First Edition: September 6, 2013

Today's headlines include a report on the White House's proposal about how to gather information that would allow the government to enforce the employer mandate, which requires companies with 50 or more workers to provide affordable health insurance to their full-time employees.

6 Sep 2013

New gene that causes cystic kidneys in children, young adults identified

Sylvia Hoff, a graduate student from the Spemann Graduate School of Biology and Medicine, has identified a new gene that causes cystic kidneys in children and young adults.

6 Sep 2013

Preventive PCI for patients with ST elevation myocardial infarction results in better outcomes

Heart attack patients with ST elevation who undergo a preventive procedure to unblock additional coronary arteries have significantly better outcomes than those whose treatment is confined to the culprit blockage only, according to the results of the Preventive Angioplasty in Myocardial Infarction (PRAMI) Trial

5 Sep 2013

Anti-diabetic drug alogliptin meets primary endpoint in EXAMINE trial

Patients with type 2 diabetes and high cardiovascular risk due to recent acute coronary syndromes had similar rates of cardiovascular events when treated with the anti-diabetic agent alogliptin compared to placebo according to results of the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial presented at the European Society of Cardiology Congress.

2 Sep 2013

After voting to cut payments to dialysis clinics, many lawmakers seek a reversal

On Capitol Hill, some lawmakers are rethinking the Medicare policy for kidney patients because clinics argue they may have to close or cut services. Elsewhere, the president of the American Medical Association is optimistic Congress will change Medicare's payment formula and a Republican senator wants all congressional staff to get coverage in Obamacare's exchanges.

30 Aug 2013

First Edition: August 29, 2013

Today's headlines include reports about ongoing fiscal fights surrounding efforts to raise the nation's debt limit and to defund the health law. Also, the White House enlists former President Bill Clinton to help spread the word about the overhaul.

29 Aug 2013

Scientists grow cells that line blood vessels from human iPSCs

In a scientific first, Harvard Stem Cell Institute scientists have successfully grown the cells that line the blood vessels-called vascular endothelial cells-from human induced pluripotent stem cells (iPSCs), revealing new details about how these cells function.

23 Aug 2013

Medicare changes appear to be driving reduced used of dialysis drugs

The Washington Post reports on a new study, which finds Food and Drug Administration warnings did not cause a sharp drop in the use of these drugs.

16 Aug 2013

New microfluidic chip can capture live CTCs from patient's blood

Tumor cells circulating within a patient's bloodstream can carry cancer from a primary tumor site to distant sites of the body, spreading the disease.

9 Aug 2013

Person with type 2 diabetes may spend nearly $85,500 to treat the disease

A person with type 2 diabetes may spend an average of nearly $85,500 to treat the disease and its complications over his or her lifetime, reports a new study in the American Journal of Preventive Medicine.

9 Aug 2013

Viewpoints: GOP's shutdown vow; Peter Orszag defends rationale behind Medicare payment board

A dozen Republicans in the Senate have said they'd rather shut down the government than provide funding for the Patient Protection and Affordable Care Act, the 2010 healthcare reform law better known as Obamacare. Meanwhile, more than 60 Republicans in the House have called on their leadership to cut off all federal support for the law in the coming fiscal year. And they complain when President Obama doesn't hold up his end of the bargain? (7/30).

1 Aug 2013

AstraZeneca, FibroGen partner to develop, commercialize anemia drug candidate FG-4592

AstraZeneca and FibroGen today announced that they have entered into a strategic collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease and end-stage renal disease.

31 Jul 2013

FibroGen, Astellas initiate Phase 2 study of ASP1517/FG-4592 for treatment of anemia linked with CKD

Astellas Pharma Inc. (Tokyo:4503) (Astellas) and FibroGen, Inc. (FibroGen) announced today the initiation of a Phase 2 clinical study in Japan of ASP1517/FG-4592 for treatment of anemia associated with chronic kidney disease (CKD) in patients on dialysis.

31 Jul 2013

NIH expands CRIC study to identify risk factors for progression of early stage CKD

Researchers from the Chronic Renal Insufficiency Cohort study are embarking on another five years of work to identify risk factors for progression of early stage chronic kidney disease, better understand the importance of reduced kidney function in older persons, and learn what role CKD may play in other illnesses that require hospitalization. CRIC is supported by the National Institutes of Health.

30 Jul 2013

Frequency, duration of patient-doctor contact important for improving health of dialysis patients

Both the frequency and duration of patient-doctor contact during dialysis care vary appreciably across countries, and facilities with more frequent and longer contact had fewer patient deaths and hospitalizations, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

26 Jul 2013

NxStage Medical revenue increases 11% to $65.5 million in Q2 2013

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported second quarter financial results with total revenue at the top end of its guidance range.

25 Jul 2013

Study shows obese kidney failure patients derive survival advantage from transplantation

Most obese individuals with kidney failure can prolong their lives by receiving a kidney transplant, although this survival benefit is lower in severely obese individuals. That's the conclusion of a new study published in the American Journal of Transplantation.

25 Jul 2013

Mortality rates declining among dialysis patients despite rise in coronary artery disease, study finds

A new study led by researchers at the University of Limerick’s Graduate Entry Medical School has found that deaths among dialysis patients are falling despite a rise in coronary artery disease.

24 Jul 2013

Detroit seeks retiree pension, health care cuts in Bankruptcy Filing

Detroit and its retirees begin a court fight this week over how much the city can cut its pension and health care benefits as it seeks to discharge $19 billion in debt.

23 Jul 2013

Dialysis News and Research

Latest Dialysis News and Research

Combination of Baxter and Gambro enable Baxter to better serve innovative renal products and therapies

First Edition: September 6, 2013

New gene that causes cystic kidneys in children, young adults identified

Preventive PCI for patients with ST elevation myocardial infarction results in better outcomes

Anti-diabetic drug alogliptin meets primary endpoint in EXAMINE trial

After voting to cut payments to dialysis clinics, many lawmakers seek a reversal

First Edition: August 29, 2013

Scientists grow cells that line blood vessels from human iPSCs

Medicare changes appear to be driving reduced used of dialysis drugs

New microfluidic chip can capture live CTCs from patient's blood

Person with type 2 diabetes may spend nearly $85,500 to treat the disease

Viewpoints: GOP's shutdown vow; Peter Orszag defends rationale behind Medicare payment board

AstraZeneca, FibroGen partner to develop, commercialize anemia drug candidate FG-4592

FibroGen, Astellas initiate Phase 2 study of ASP1517/FG-4592 for treatment of anemia linked with CKD

NIH expands CRIC study to identify risk factors for progression of early stage CKD

Frequency, duration of patient-doctor contact important for improving health of dialysis patients

NxStage Medical revenue increases 11% to $65.5 million in Q2 2013

Study shows obese kidney failure patients derive survival advantage from transplantation

Mortality rates declining among dialysis patients despite rise in coronary artery disease, study finds

Detroit seeks retiree pension, health care cuts in Bankruptcy Filing

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Dialysis News and Research

Latest Dialysis News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in